Condition: Bradycardia · Remote Monitoring · Sponsor: MicroPort CRM
The purpose of the clinical investigation is to document the safety and the performances of the remote monitoring functions of the ALIZEA, BOREA and CELEA pacemakers, i.e. the RAAT, the RVAT and the remote alerts.
This description comes directly from the study's public registry record.
Antoine Guihard · +33 1 46 01 33 20 · antoine.guihard@crm.microport.com
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Krems | Krems, Austria | Recruiting |
| Allgemeines Krankenhaus Wien | Vienna, Austria | Recruiting |
| Clinique Saint Joseph | Arlon, Belgium | Recruiting |
| CHU Bordeaux | Bordeaux, France | Recruiting |
| CH Chartres | Le Coudray, France | Recruiting |
| CHU Hôpital de la Timone | Marseille, France | Recruiting |
| CHU Nantes | Nantes, France | Recruiting |
| Clinique Pasteur Toulouse | Toulouse, France | Recruiting |
| CH Valence | Valence, France | Recruiting |
| Cardiologicum Hamburg | Hamburg, Germany | Recruiting |
| Cardiologicum Pirna | Pirna, Germany | Recruiting |
| Kardiologische Praxis Dr. Trautwein & Dr. Placke | Rostock, Germany | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05165095